In September 2024, Sanofi entered an exclusive licensing agreement with Orano Med and RadioMedix to globally commercialize ...
In a major development for diabetes care in India, Dr. Reddy's Labs has got the go-ahead from the Subject Expert Committee ...
Obesity has long been known as a risk factor for a host of diseases like cancer and dementia, but researchers now say that ...
A real weight loss drug, called retatrutide, is currently being developed by pharmaceutical giant Eli Lilly, but there has ...
212Pb-DOTAMTATE showed significant antitumor activity in PRRT-exposed GEP-NETs, with a 34.6% objective response rate and 96.2% disease control rate. The 18-month progression-free survival and overall ...